Role of venous duplex imaging of the lower extremities in patients with fever of unknown origin

Surgery

Volumn 121, Issue 4, 1997, Pages 366-371

  AbuRahma, Ali F ^a   Saiedy, Samer ^a   Robinson, Patrick A ^a   Boland, James P ^a   Cottrell IV, Dominic J ^a   Stuart, Cheryle ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; COST; COST BENEFIT ANALYSIS; DEEP VEIN THROMBOSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PHLEBOGRAPHY; PRIORITY JOURNAL; PYREXIA IDIOPATHICA;

EID: 0030941478     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-6060(97)90305-6     Document Type: Article

References (14)

1. Petersdorf RG, Beeson PB. Fever of unexplained origin: report on 100 cases. Medicine 1961;40:1-30.
2. Kazanjian PH. Fever of unknown origin: review of 86 patients treated in community hospitals. Clin Infect Dis 1992;15:968-73.
3. Jacoby GA, Swartz MN. Medical Intelligence: current Concepts-fever of undetermined origin. New Engl J Med 1973;289:1407-10.
4. Goetz MB. Fever of unknown origin in the elderly. Infectious Diseases in Clinical Practice 1993;2:377-83.
5. Brusch JL, Weinstein L. Fever of unknown origin. Med Clin North Am 1988;72:1247-61.
6. DiNubile MJ. Acute fevers of unknown origin: a plea for restraint. Arch Intern Med 1993;153:2525-6.
7. Gardner-Medwin JMM, Lim KL, Powell RJ. Fever as an unusual presentation of a common condition. Ann Rheum Dis 1994;53:711-3.
8. Larson EB, Featherstone HJ, Petersdorf RG. Fever of undetermined origin: diagnosis and follow-up of 105 cases, 1970-1980. Medicine 1982;61:269-92.
9. Knockaert DC, Vanneste LJ, Bobbaers HJ. Fever of unknown origin in elderly patients. J Am Geriatr Soc 1993;41:1187-92.
10. Smith JW. Southwestern Internal Medicine Conference: fever of undetermined origin - not what it used to be. Am J Med Sci 1986;292:56-64.
11. Bartlett MR, Cowden WB, Parish CR. Differential effects of the antiinflammatory compounds heparin, mannose-6-phosphate, and castanospermine on degradation of the vascular basement membrane by leukocytes, endothelial cells, and platelets. J Leukoc Biol 1995;57:207-13.
12. Minter AJ, Keoshkerian E, Chesterman CN, Dawes J. Fibroblast growth factor and heparin protect endothelial cells from the effects of interleukin-1. J Cell Physiol 1996;167:229-37.
13. El-Habbal MH, Smith L, Elliott MJ, Strobel S. Effect of heparin anticoagulation on neutrophil adhesion molecules and release of ILi: C3 is not essential. Cardiovasc Res 1995;30:676-81.
14. Frieri M, Agarwal K, Datar A, Trotta P. Increased interleukin-4 production in response to mast cell mediators and human type I collagen in patients with rheumatoid arthritis. Ann Allergy 1994;72:360-7.